Our impact
Building on our purpose, we focus our impact efforts on five key areas
Dedicated to increasing access to medicines
We have established a comprehensive goal - Lilly 30x30 - to improve access to quality health care for 30 million people living in communities with limited resources, annually by 2030.
Our 2030 Environmental Goals
Minimize our
environmental impact
including energy, water and raw materials. We’re
committed to continually improving our environmental
impact across our product life cycles and supply chain. We
have set new sustainability goals to reduce our emissions
and waste and to continue using water responsibly and
efficiently.
Climate
Carbon neutral in our own operations
100% renewable electricity
Enhance full value-chain emissions reporting
Waste
Zero waste to landfills from routine operations
100% of plastic waste for beneficial use, with at least 90% recycled or reused
Integrate sustainability into product and packaging design
Water
No adverse impact to water-stressed areas
No adverse impact from pharmaceuticals in the environment
We’re Improving Lives and Communities
We’re Cultivating an Inclusive Culture
Everything We Do Starts with Operating Ethically and Responsibly
2024 Year in Review
Sustainability Report
Lilly Cautionary Statement Regarding Forward-Looking Statements
This website contains forward-looking statements that are based on management’s assumptions and expectations at the time the statements were posted, including statements regarding our sustainability targets, goals, commitments and programs and other business plans, initiatives, aspirations and objectives. The words “estimate”, “project”, “intend”, “expect”, “believe”, “target”, “anticipate” and similar expressions are intended to identify forward-looking statements. All such statements are intended to enjoy the protection of the safe harbor for forward-looking statements provided by the Private Securities Litigation Reform Act of 1995, as amended. Actual results may differ materially due to various factors. The company’s sustainability targets, goals, and commitments outlined in this website or elsewhere, as well as its operations, results, business, goals, and strategy may be affected by factors including, but not limited to, the impact of the evolving COVID-19 pandemic (or any other public health threat) and the global response thereto; the significant costs and uncertainties in the pharmaceutical research and development process, including with respect to the timing and process of obtaining regulatory approvals; competitive developments affecting current products and the company’s pipeline; regulatory actions regarding currently marketed products; litigation, investigations, or other similar proceedings involving past, current, or future products or commercial activities as the company is largely self-insured; the impact and outcome of business development transactions and related integration costs; the impact of global macroeconomic conditions, trade disruptions, disputes, unrest, war or other costs or uncertainties related to doing business in foreign jurisdictions; issues with product supply and regulatory approvals stemming from manufacturing difficulties, disruptions or shortages, including as a result of demand, labor shortages, third-party performance or regulatory actions relating to our facilities; and changes or developments in laws and regulations, including health care reform.
For additional information about the factors that affect the company’s business, please see the company’s latest Forms 10-K, 10-Q, and any 8-Ks filed with the Securities and Exchange Commission. The company expressly disclaims any obligation to update forward-looking statements except as required by applicable law.
Find more detail on Lilly’s environmental, social and governance priorities, strategies and operations.